| Pseudo-anaphylaxis to polyethylene glycol (PEG)-coated liposomes: roles of anti-PEG IgM and complement activation in a porcine model of human infusion reactions GT Kozma, T Mészáros, I Vashegyi, T Fülöp, E Örfi, L Dézsi, ... Acs Nano 13 (8), 9315-9324, 2019 | 155 | 2019 |
| Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: Evaluation of size-dependent imaging properties, storage stability and safety H Unterweger, L Dézsi, J Matuszak, C Janko, M Poettler, J Jordan, ... International journal of nanomedicine, 1899-1915, 2018 | 135 | 2018 |
| Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging H Unterweger, C Janko, M Schwarz, L Dézsi, R Urbanics, J Matuszak, ... International journal of nanomedicine, 5223-5238, 2017 | 99 | 2017 |
| Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses L Dézsi, T Fülöp, T Mészáros, G Szénási, R Urbanics, C Vázsonyi, E Őrfi, ... Journal of controlled release 195, 2-10, 2014 | 95 | 2014 |
| Evidence for the expression of cyclooxygenase-2 enzyme in periodontitis Z Lohinai, R Stachlewitz, AD Szekely, E Feher, L Dézsi, C Szabó Life sciences 70 (3), 279-290, 2001 | 78 | 2001 |
| Selective inhibition of endothelium-dependent dilation in resistance-sized vessels in vivo U Pohl, L Dezsi, B Simon, R Busse American Journal of Physiology-Heart and Circulatory Physiology 253 (2 …, 1987 | 76 | 1987 |
| From design to the clinic: practical guidelines for translating cardiovascular nanomedicine I Cicha, C Chauvierre, I Texier, C Cabella, JM Metselaar, J Szebeni, ... Cardiovascular research 114 (13), 1714-1727, 2018 | 71 | 2018 |
| Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing J Matuszak, J Baumgartner, J Zaloga, M Juenet, AE da Silva, D Franke, ... Nanomedicine 11 (6), 597-616, 2016 | 64 | 2016 |
| Acute improvement in histological outcome by MK-801 following focal cerebral ischemia and reperfusion in the cat independent of blood flow changes L Dezsi, JH Greenberg, J Hamar, J Sladky, A Karp, M Reivich Journal of Cerebral Blood Flow & Metabolism 12 (3), 390-399, 1992 | 57 | 1992 |
| Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke L Dézsi, I Kis-Varga, J Nagy, Z Komlódi, E Kárpáti Acta Pharmaceutica Hungarica 72 (2), 84-91, 2002 | 52 | 2002 |
| Effect of transient receptor potential vanilloid 1 (TRPV1) receptor antagonist compounds SB705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an … V Tékus, Á Kis-Varga, L Dézsi, É Szentirmay, A Visegrády, C Horváth, ... European journal of pharmacology 641 (2-3), 135-141, 2010 | 44 | 2010 |
| Prolonged effects of MK-801 in the cat during focal cerebral ischemia and recovery: survival, EEG activity and histopathology L Dezsi, JH Greenberg, J Sladky, N Araki, J Hamar, M Reivich Journal of the neurological sciences 121 (1), 110-120, 1994 | 34 | 1994 |
| Preparation of intramural small coronary artery and arteriole segments and resistance artery networks from the rat heart for microarteriography and for in situ perfusion video … GL Nádasy, M Szekeres, L Dézsi, S Várbiró, B Székács, E Monos Microvascular research 61 (3), 282-286, 2001 | 33 | 2001 |
| Antinociceptive desensitizing actions of TRPV1 receptor agonists capsaicin, resiniferatoxin and N-oleoyldopamine as measured by determination of the noxious heat and cold … V Tékus, L Dézsi, J Szolcsányi, G Pethő European Journal of Pain 14 (5), 480-486, 2010 | 32 | 2010 |
| Concomitant accumulation of intracellular free calcium and arachidonic acid in the ischemic-reperfused rat heart T Ivanics, Z Miklós, L Dézsi, K Ikrényi, A Tóth, THM Roemen, ... Molecular and cellular biochemistry 226, 119-128, 2001 | 31 | 2001 |
| A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a … L Dézsi, T Mészáros, G Kozma, M H-Velkei, CZ Oláh, M Szabó, Z Patkó, ... GeroScience, 2022 | 30 | 2022 |
| Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk C Lengyel, L Dézsi, P Biliczki, C Horváth, L Virág, N Iost, M Németh, ... British journal of pharmacology 143 (1), 152-158, 2004 | 28 | 2004 |
| Pharmaceutical development and safety evaluation of a GMP-grade fucoidan for molecular diagnosis of cardiovascular diseases C Chauvierre, R Aid-Launais, J Aerts, F Chaubet, M Maire, L Chollet, ... Marine drugs 17 (12), 699, 2019 | 27 | 2019 |
| A porcine model of complement activation-related pseudoallergy to nano-pharmaceuticals: Pros and cons of translation to a preclinical safety test J Szebeni, P Bedőcs, L Dézsi, R Urbanics Prec Nanomed 1, 63-73, 2018 | 26 | 2018 |
| Importance of extracardiac α1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts AS Farkas, K Acsai, A Tóth, L Dézsi, S Orosz, T Forster, M Csanády, ... European journal of pharmacology 537 (1-3), 118-125, 2006 | 26 | 2006 |
Janos SzebeniNanomedicine Research and Education Center, Semmelweis UniversityEmail verificata su seroscience.com
